Compare Cassava Sciences Inc (FLNA) vs Gold Fields Limited (GFI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Gold Fields Limited — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Gold Fields Limited trades at $32.32 (market cap $29.07B). The key difference: Gold Fields Limited is far larger — about 547× Cassava Sciences Inc's market cap, and Gold Fields Limited pays a 7.03% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | GFI | |
|---|---|---|
Market Cap | $53.14M | $29.07B |
Sector | Health | Basic Materials |
52-Week High | $4.64 | $61.52 |
52-Week Low | $1.09 | $23.95 |
Enterprise Value | -$33.43M | $30.51B |
Dividend Yield | — | 7.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Gold Fields (GFI) trades at $33.33, down 0.6% with a bearish technical signal despite strong fundamental metrics including a P/E of 8.37, net income margin of 40.76%, and ROE of 52.33%. Recent earnings show mixed results with a Q1 2025 beat but subsequent misses. The company demonstrates robust cash flow growth with 2025 operating cash flow projected at $3.8B, while technical indicators show oversold conditions with RSI at 26.87.
GFI presents a compelling value opportunity with attractive valuation multiples and exceptional profitability metrics, though recent earnings misses and bearish technical momentum create near-term uncertainty. The 57% upside to the $52.75 consensus price target suggests significant potential, but investors should monitor operational execution and gold price volatility as key risk factors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Gold Fields Limited
Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is primarily involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.
Read more on GFI →
